SOURCE: Industrial Info Resources

Industrial Info Resources

April 12, 2012 06:30 ET

North America Remains Strongest Link in Global Pharma-Biotech Industry Chain, a "Navigating the Currents of Change" Webcast on

SUGAR LAND, TX--(Marketwire - Apr 12, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- There is no arguing that the entire Pharma-Biotech Industry has undergone a massive reorganization that is still not complete. But reports of the industry's demise were premature to say the least. The truth of the matter can always be found in the facts, and the fact is that the industry continues to spur billions of dollars in new capital investment each year. And this is a figure that is trending back up from the lows of a couple of years ago, when virtually every industry was slammed by the economic tsunami.

A recent analysis of North American projects found in the Pharmaceutical-Biotech Tracker - Online Database reveals 713 active capital and maintenance (MRO) projects, with a combined total investment value (TIV) of $14.5 billion, that are scheduled to begin construction in 2012. The undeniable fact of this spending should encourage the more widespread use of another truism when referring to the industry: Even when things are really bad, they're still pretty good.

Visit to join Annette Kreuger, Industrial Info's vice president for Pharmaceutical-Biotech Industry research, in this week's "Navigating the Currents of Change" webcast for an in-depth discussion on the industry that touches everyone's life.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Joe Govreau